Prolonged Impella 5.5 Support in a Pediatric Patient With Genetic Cardiomyopathy
- 2 July 2025
- journal article
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (6) , 861-863
Abstract
Temporary mechanical circulatory support (tMCS) has been utilized as a bridge to heart transplantation with increasing duration of support. We describe the clinical course of a 14-year-old patient, with TNNT2 and KCNQ1 mutations, requiring Impella 5.5 support for 76 days. We discuss the patient's underlying genetic etiology, potential complications of prolonged tMCS, and the importance of multidisciplinary support. To our knowledge, this is the first published case in which a patient has this specific combination of genetic mutations and the longest published support duration of an Impella 5.5 in a pediatric patient.Keywords
This publication has 5 references indexed in Scilit:
- Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart centerThe Journal of Thoracic and Cardiovascular Surgery, 2022
- Weaning from Impella and mobilization of Impella patientsEuropean Heart Journal Supplements, 2021
- Disorders of Adjustment, Mood, and Anxiety in Children and Adolescents Undergoing Heart Transplantation and the Association of Ventricular Assist Device SupportThe Journal of Pediatrics, 2020
- Psychosocial functioning in pediatric heart transplant recipients and their familiesPediatric Transplantation, 2018
- A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patientsCatheterization and Cardiovascular Interventions, 2017